Authors: Fries, LF Montemarano, AD Mallett, CP Taylor, DN Hale, TL Lowell, GH

Citation: Lf. Fries et al., Safety and immunogenicity of a proteosome-Shigella flexneri 2a lipopolysaccharide vaccine administered intranasally to healthy adults, INFEC IMMUN, 69(7), 2001, pp. 4545-4553

Authors: Teska, JD Coster, T Byrne, WR Colbert, JR Taylor, D Venkatesan, M Hale, TL

Citation: Jd. Teska et al., Novel self-sampling culture method to monitor excretion of live, oral Shigella flexneri 2a vaccine SC602 during a community-based phase 1 trial, J LA CL MED, 134(2), 1999, pp. 141-146

Authors: Coster, TS Hoge, CW Van de Verg, LL Hartman, AB Oaks, EV Venkatesan, MM Cohen, D Robin, G Fontaine-Thompson, A Sansonetti, PJ Hale, TL

Citation: Ts. Coster et al., Vaccination against shigellosis with attenuated Shigella flexneri 2a strain SC602, INFEC IMMUN, 67(7), 1999, pp. 3437-3443